Is Novo Nordisk Stock a Millionaire Maker?
Danish pharmaceutical company Novo Nordisk (NYSE: NVO) has established itself as one of the top healthcare stocks in the world with a market cap hovering around $600 billion. Long-term investors earned fantastic returns; in just five years, the share prices of Novo Nordisk are up over 450%. But what about investors who buy the stock today?
Does Novo Nordisk have the potential to keep generating great returns? And could those returns be strong enough to eventually make new investors into millionaires? Let's take a look at whether the healthcare stock could make for a great buy right now.
Novo Nordisk has multiple drugs that treat issues getting a lot of attention in healthcare -- obesity and diabetes. People who are overweight or who have diabetes often have other healthcare issues as well. By focusing on these areas, Novo Nordisk's drugs can potentially improve health conditions that go far beyond what the drugs' initial indications would suggest.
Source Fool.com
